Genomic analysis of vaginal microbiota in female patients with systemic lupus erythematosus

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100053646

Enrollment

Unknown

Registered

2021-11-26

Start date

2021-11-20

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus

Interventions

SLE initial treatment group:None

Retreatment group:None

Control group:None

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.SLE diagnosis meets EULAR/ACR 2019 classification criteria; 2.Have a sexual history; 3.Sign the relevant informed consent.

Exclusion criteria

Exclusion criteria: 1.Complicated with allergic diseases; 2.Complicated with malignant tumor; 3.Complicated with tuberculosis; 4.With other connective tissue diseases except SLE; 5.Combined with immune deficiency diseases; 6.Sexual life history within the last 7 days; 7.A history of systemic antibiotic use or vaginal irrigation within the past 1 month; 8.Pregnancy, diabetes, lactation, menstruation; 9.Clear bacterial vaginosis, trichomonas, mold, HPV and other infections.

Design outcomes

Primary

Measure	Time frame
Species abundance of vaginal flora;Structure of vaginal flora;	—

Countries

China

Contacts

Public ContactLin Youkun

The First Affiliated Hospital of Guangxi Medical University

linyoukun7@aliyun.com+86 13507883737

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026